These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2435558)

  • 41. [The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers].
    Asskali F; Förster H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Sep; 34(9):537-41. PubMed ID: 10542895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pharmacokinetics of acetyl starch as a plasma volume expander in patients undergoing elective surgery.
    Behne M; Thomas H; Bremerich DH; Lischke V; Asskali F; Förster H
    Anesth Analg; 1998 Apr; 86(4):856-60. PubMed ID: 9539615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
    Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
    Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Decrease of thrombocyte volume after several days infusion of highly substituted medium molecular weight hydroxyethyl starch (HAES 200/0.62)].
    Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
    Wien Klin Wochenschr; 1996; 108(1):20-3. PubMed ID: 8677658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haemodilution with dextran 40 and hydroxyethyl starch and its effect on cerebral microcirculation.
    Scharf J; von Kummer R; Back T; Reich H; Machens G; Wildemann B
    J Neurol; 1989 Mar; 236(3):164-7. PubMed ID: 2468744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution.
    Ickx BE; Bepperling F; Melot C; Schulman C; Van der Linden PJ
    Br J Anaesth; 2003 Aug; 91(2):196-202. PubMed ID: 12878617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjusted hypervolemic hemodilution in acute ischemic stroke.
    Koller M; Haenny P; Hess K; Weniger D; Zangger P
    Stroke; 1990 Oct; 21(10):1429-34. PubMed ID: 1699308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT.
    Konrad CJ; Markl TJ; Schuepfer GK; Schmeck J; Gerber HR
    Anesth Analg; 2000 Feb; 90(2):274-9. PubMed ID: 10648306
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The influence of hydroxyethyl starch on blood clotting (author's transl)].
    Peter K; Gander HP; Lutz H; Nold W; Stosiek U
    Anaesthesist; 1975 May; 24(5):219-24. PubMed ID: 56903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of hydroxyethyl starch in normal subjects.
    Yacobi A; Stoll RG; Sum CY; Lai CM; Gupta SD; Hulse JD
    J Clin Pharmacol; 1982 Apr; 22(4):206-12. PubMed ID: 6178760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rational use of albumin and plasma substitutes.
    Thompson WL
    Johns Hopkins Med J; 1975 May; 136(5):220-5. PubMed ID: 47936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Rheological and expander effect of hydroxyethyl-starch in intradural anesthesia].
    González de Zárate Apiñaniz J; Catón Valdés MM; Alvarez López JC; Vega Sánchez JM; Ojeda Ortego J
    Rev Esp Anestesiol Reanim; 1991; 38(2):90-3. PubMed ID: 1715092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography.
    Jamnicki M; Zollinger A; Seifert B; Popovic D; Pasch T; Spahn DR
    Anesth Analg; 1998 Nov; 87(5):989-93. PubMed ID: 9806670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary hemostasis in hemodilution--2) Infusion solutions.
    Dietrich G; Orth D; Haupt W; Kretschmer V
    Infusionstherapie; 1990 Aug; 17(4):214-6. PubMed ID: 1698720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)].
    Jung F; Waldhausen P; Spitzer S; Wenzel E
    Acta Med Austriaca; 1991; 18 Suppl 1():9-15. PubMed ID: 1719736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hydroxyethyl starch 200/0.5 reduces infarct volume after embolic stroke in rats.
    Perez-Trepichio AD; Furlan AJ; Little JR; Jones SC
    Stroke; 1992 Dec; 23(12):1782-90; discussion 1790-1. PubMed ID: 1280378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine (author's transl)].
    Köhler H; Zschiedrich H; Linfante A; Appel F; Pitz H; Clasen R
    Klin Wochenschr; 1982 Mar; 60(6):293-301. PubMed ID: 6176754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The influence of different plasma substitutes on blood clotting in isovolaemic haemodilution (author's transl)].
    Martin E; Armbruster I; Fischer E; Kraatz J; Kersting KH; Oberst R; Peter K
    Anaesthesist; 1976 Apr; 25(4):181-4. PubMed ID: 58563
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation.
    Egli GA; Zollinger A; Seifert B; Popovic D; Pasch T; Spahn DR
    Br J Anaesth; 1997 Jun; 78(6):684-9. PubMed ID: 9215020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Changes in coagulation physiology and rheology after preoperative normovolemic hemodilution].
    Hensel M; Wrobel R; Volk T; Pahlig H; Kox WJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Oct; 31(8):481-7. PubMed ID: 9019177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.